Since 2000, the WHO has been revising the gastroenteropancreatic classification to avoid the term “carcinoid” in favor of NET; currently, NET is classified by tumor differentiation, mitotic rate, and Ki-67 in the pathology report [16]. Here, MKI67 is linked to carcinoid tumor.